These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 31616060)

  • 1. The ever-changing world of gene fusions in cancer: a secondary gene fusion and progression.
    Powers MP
    Oncogene; 2019 Nov; 38(47):7197-7199. PubMed ID: 31616060
    [No Abstract]   [Full Text] [Related]  

  • 2. Commonality but diversity in cancer gene fusions.
    Rabbitts TH
    Cell; 2009 May; 137(3):391-5. PubMed ID: 19410533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncogenic Gene Fusion Detection Using Anchored Multiplex Polymerase Chain Reaction Followed by Next Generation Sequencing.
    Seager M; Aisner DL; Davies KD
    J Vis Exp; 2019 Jul; (149):. PubMed ID: 31329176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TRK Fusion Cancer: Patient Characteristics and Survival Analysis in the Real-World Setting.
    Bazhenova L; Lokker A; Snider J; Castellanos E; Fisher V; Fellous M; Nanda S; Zong J; Keating K; Jiao X
    Target Oncol; 2021 May; 16(3):389-399. PubMed ID: 33893941
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Trombetta D; Sparaneo A; Muscarella LA
    Future Oncol; 2021 Feb; 17(5):487-490. PubMed ID: 33399024
    [No Abstract]   [Full Text] [Related]  

  • 6. ROS1 fusions in cancer: a review.
    Uguen A; De Braekeleer M
    Future Oncol; 2016 Aug; 12(16):1911-28. PubMed ID: 27256160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Driver Fusions and Their Implications in the Development and Treatment of Human Cancers.
    Gao Q; Liang WW; Foltz SM; Mutharasu G; Jayasinghe RG; Cao S; Liao WW; Reynolds SM; Wyczalkowski MA; Yao L; Yu L; Sun SQ; ; ; Chen K; Lazar AJ; Fields RC; Wendl MC; Van Tine BA; Vij R; Chen F; Nykter M; Shmulevich I; Ding L
    Cell Rep; 2018 Apr; 23(1):227-238.e3. PubMed ID: 29617662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expanding the spectrum of cancer targets by predicting individual gene fusions.
    Nat Biotechnol; 2022 Aug; 40(8):1188-1189. PubMed ID: 35383308
    [No Abstract]   [Full Text] [Related]  

  • 9. The landscape and therapeutic relevance of cancer-associated transcript fusions.
    Yoshihara K; Wang Q; Torres-Garcia W; Zheng S; Vegesna R; Kim H; Verhaak RG
    Oncogene; 2015 Sep; 34(37):4845-54. PubMed ID: 25500544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methods for Identifying Patients with Tropomyosin Receptor Kinase (TRK) Fusion Cancer.
    Wong D; Yip S; Sorensen PH
    Pathol Oncol Res; 2020 Jul; 26(3):1385-1399. PubMed ID: 31256325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and Clinical Validation of a Large Fusion Gene Panel for Pediatric Cancers.
    Chang F; Lin F; Cao K; Surrey LF; Aplenc R; Bagatell R; Resnick AC; Santi M; Storm PB; Tasian SK; Waanders AJ; Hunger SP; Li MM
    J Mol Diagn; 2019 Sep; 21(5):873-883. PubMed ID: 31255796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptome sequencing to detect gene fusions in cancer.
    Maher CA; Kumar-Sinha C; Cao X; Kalyana-Sundaram S; Han B; Jing X; Sam L; Barrette T; Palanisamy N; Chinnaiyan AM
    Nature; 2009 Mar; 458(7234):97-101. PubMed ID: 19136943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovering and understanding oncogenic gene fusions through data intensive computational approaches.
    Latysheva NS; Babu MM
    Nucleic Acids Res; 2016 Jun; 44(10):4487-503. PubMed ID: 27105842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of recurrent fusion genes across multiple cancer types.
    Yu YP; Liu P; Nelson J; Hamilton RL; Bhargava R; Michalopoulos G; Chen Q; Zhang J; Ma D; Pennathur A; Luketich J; Nalesnik M; Tseng G; Luo JH
    Sci Rep; 2019 Jan; 9(1):1074. PubMed ID: 30705370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. annoFuse: an R Package to annotate, prioritize, and interactively explore putative oncogenic RNA fusions.
    Gaonkar KS; Marini F; Rathi KS; Jain P; Zhu Y; Chimicles NA; Brown MA; Naqvi AS; Zhang B; Storm PB; Maris JM; Raman P; Resnick AC; Strauch K; Taroni JN; Rokita JL
    BMC Bioinformatics; 2020 Dec; 21(1):577. PubMed ID: 33317447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene Fusions in Human Cancers: A Review Focused on Diagnostic Biomarkers, Method Selections, and Treatments.
    Ni H; Wang XT; Fang R; Zhou XJ; Rao Q
    Crit Rev Oncog; 2017; 22(5-6):403-410. PubMed ID: 29604920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Testing algorithm for identification of patients with TRK fusion cancer.
    Penault-Llorca F; Rudzinski ER; Sepulveda AR
    J Clin Pathol; 2019 Jul; 72(7):460-467. PubMed ID: 31072837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identifying patients with NTRK fusion cancer.
    Solomon JP; Benayed R; Hechtman JF; Ladanyi M
    Ann Oncol; 2019 Nov; 30(Suppl_8):viii16-viii22. PubMed ID: 31738428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular Pathways: Targeting NRG1 Fusions in Lung Cancer.
    Fernandez-Cuesta L; Thomas RK
    Clin Cancer Res; 2015 May; 21(9):1989-94. PubMed ID: 25501131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene fusions in tumourigenesis with particular reference to ovarian cancer.
    Zhou Y; El-Bahrawy M
    J Med Genet; 2021 Dec; 58(12):789-795. PubMed ID: 34462289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.